
This is what you will do:
The Associate Director, U.S. Marketing, PNH, is a core member of the commercial PNH (Paroxysmal Nocturnal Hemoglobinuria) brand team. This position will play a critical role driving innovation, with responsibility for leading planning, implementation, and measurement of the omni-channel approach, with a focus on media & digital ecosystems, across disease state & branded promotion. This individual will also have selected responsibilities and projects to optimize our HCP & Patient marketing efforts helping to ensure strategic and tactical alignment across both internal and external stakeholders
You will be responsible for:
You will need to have:
We would prefer for you to have:
The annual base pay (or hourly rate of compensation) for this position ranges from $151,082 to $226,622. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.
Date Posted
21-May-2026
Closing Date
03-Jun-2026
Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy